NASDAQ : RXRX
Recursion Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.03 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.41B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Recursion Pharmaceuticals, Inc. (RXRX) reported revenue of 54.86M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 54.86M | 74.68M | 58.84M | 44.58M | 39.84M | 10.18M |
| Cost of Revenue | 447.46M | 546.22M | 359.66M | 283.81M | 203.97M | 135.27M |
| Gross Profit | -392.60M | -471.54M | -300.82M | -239.24M | -164.13M | -125.09M |
| Selling, General & Admin | 157.37M | 176.59M | 178.18M | 110.82M | 81.60M | 57.68M |
| Operating Expenses | 157.37M | 176.59M | 178.18M | 110.82M | 81.60M | 57.68M |
| Operating Income | -549.97M | -648.13M | -479.00M | -350.06M | -245.73M | -182.78M |
| Interest Expense | -1.48M | -1.81M | -1.57M | -97.00K | -55.00K | -2.95M |
| Interest & Investment Income | 23.06M | 22.79M | 15.76M | 19.12M | 6.25M | 73.00K |
| Other Non Operating Income (Expenses) | -1.03M | -17.74M | 30.00K | -1.09M | 52.00K | 2.00K |
| EBT Excluding Unusual Items | -529.42M | -644.89M | -464.79M | -332.13M | -239.48M | -185.65M |
| Other Unusual Items | -827.00K | |||||
| Pretax Income | -523.47M | -644.89M | -464.79M | -332.13M | -239.48M | -186.48M |
| Income Tax Expense | -4.58M | -136.00K | -1.13M | -4.06M | ||
| Net Income | -518.88M | -644.76M | -463.66M | -328.07M | -239.48M | -186.48M |
| Net Income to Common | -518.88M | -644.76M | -463.66M | -328.07M | -239.48M | -186.48M |
| Shares Outstanding (Basic) | 507.76M | 447.45M | 274.21M | 207.85M | 175.54M | 125.35M |
| Shares Outstanding (Diluted) | 507.76M | 447.45M | 274.21M | 207.85M | 175.54M | 125.35M |
| EPS (Basic) | -1.02 | -1.44 | -1.69 | -1.58 | -1.36 | -1.49 |
| EPS (Diluted) | -1.02 | -1.44 | -1.69 | -1.58 | -1.36 | -1.49 |
| Free Cash Flow | -352.27M | -378.28M | -372.87M | -299.74M | -120.58M | -198.41M |
| Free Cash Flow Per Share | -0.69 | -0.84 | -1.36 | -1.44 | -0.69 | -1.58 |
| Operating Margin | -1,002.56% | -867.87% | -814.09% | -785.33% | -616.74% | -1,795.79% |
| Profit Margin | -945.90% | -863.35% | -788.02% | -735.99% | -601.05% | -1,832.18% |
| Free Cash Flow Margin | -642.17% | -506.52% | -633.71% | -672.43% | -302.64% | -1,949.42% |
| EBITDA | -471.60M | -564.43M | -442.51M | -325.66M | -233.97M | -174.37M |
| D&A For EBITDA | 78.36M | 83.70M | 36.49M | 24.40M | 11.76M | 8.40M |
| EBIT | -549.97M | -648.13M | -479.00M | -350.06M | -245.73M | -182.78M |
| Revenue as Reported | 54.86M | 74.68M | 58.84M | 44.58M | 39.84M | 10.18M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 545.68M | 743.29M | 594.35M | 391.56M | 549.91M | 285.12M |
| Short-Term Investments | 231.45M | |||||
| Cash & Short-Term Investments | 545.68M | 743.29M | 594.35M | 391.56M | 549.91M | 516.56M |
| Accounts Receivable | 34.00K | |||||
| Other Receivables | 14.39M | 24.65M | 49.17M | 3.09M | 2.75M | 9.06M |
| Receivables | 14.39M | 24.65M | 49.17M | 3.09M | 2.75M | 9.09M |
| Prepaid Expenses | 8.68M | 11.74M | 29.60M | |||
| Restricted Cash | 5.38M | 4.59M | 3.04M | 3.23M | 1.28M | 1.55M |
| Other Current Assets | 29.32M | 28.57M | 38.11M | 40.25M | 15.87M | 7.51M |
| Total Current Assets | 603.46M | 812.85M | 714.27M | 438.14M | 569.81M | 534.72M |
| Property, Plant & Equipment | 147.07M | 169.48M | 233.21M | 120.17M | 121.45M | 64.72M |
| Long-Term Investments | 4.40M | |||||
| Goodwill | 160.35M | 162.16M | 148.87M | 52.06M | 801.00K | 801.00K |
| Other Intangible Assets | 282.89M | 309.90M | 335.86M | 36.44M | 1.31M | 1.39M |
| Long-Term Deferred Tax Assets | 957.00K | 957.00K | 1.93M | |||
| Other Long-Term Assets | 17.94M | 14.39M | 14.45M | 6.89M | 7.92M | 8.72M |
| Total Assets | 1.21B | 1.47B | 1.45B | 653.70M | 701.29M | 610.35M |
| Accounts Payable | 12.67M | 18.12M | 21.61M | 3.95M | 4.59M | 2.82M |
| Accrued Expenses | 54.86M | 69.53M | 80.28M | 41.76M | 30.29M | 27.67M |
| Current Portion of Long-Term Debt | 9.44M | 124.00K | 114.00K | 41.00K | 97.00K | 90.00K |
| Current Portion of Leases | 13.25M | 21.63M | 22.11M | 6.12M | 5.95M | |
| Current Unearned Revenue | 29.50M | 37.60M | 61.77M | 36.43M | 56.73M | 10.00M |
| Other Current Liabilities | 171.00K | 703.00K | 1.59M | 4.87M | 2.62M | 6.08M |
| Total Current Liabilities | 119.89M | 147.71M | 187.47M | 93.17M | 100.27M | 46.66M |
| Long-Term Debt | 4.75M | 193.00K | 684.00K | 1.10M | 536.00K | 633.00K |
| Long-Term Leases | 39.19M | 56.02M | 85.59M | 43.41M | 44.42M | |
| Long-Term Unearned Revenue | 112.82M | 114.01M | 118.77M | 51.24M | 70.26M | 6.67M |
| Long-Term Deferred Tax Liabilities | 18.31M | 23.25M | 16.57M | 1.34M | ||
| Other Long-Term Liabilities | 2.70M | 2.08M | 4.73M | 13.45M | ||
| Total Liabilities | 297.67M | 343.26M | 413.82M | 190.26M | 215.48M | 67.41M |
| Common Stock | 5.00K | 5.00K | 4.00K | 2.00K | 2.00K | 2.00K |
| Additional Paid-In Capital | 3.21B | 3.17B | 2.47B | 1.43B | 1.13B | 943.14M |
| Retained Earnings | -2.32B | -2.08B | -1.43B | -967.62M | -639.56M | -400.08M |
| Comprehensive Income & Other | 27.99M | 36.72M | -7.64M | -126.00K | ||
| Total Common Equity | 915.00M | 1.13B | 1.03B | 463.44M | 485.81M | 542.94M |
| Shareholders' Equity | 915.00M | 1.13B | 1.03B | 463.44M | 485.81M | 542.94M |
| Total Liabilities & Equity | 1.21B | 1.47B | 1.45B | 653.70M | 701.29M | 610.35M |
| Total Debt | 66.64M | 77.97M | 108.49M | 50.67M | 51.01M | 723.00K |
| Net Cash (Debt) | 479.05M | 665.33M | 485.86M | 340.89M | 498.91M | 515.84M |
| Net Cash Per Share | 0.94 | 1.49 | 1.77 | 1.64 | 2.84 | 4.12 |
| Filing Date Shares Outstanding | 535.34M | 527.40M | 401.99M | 234.65M | 191.23M | 170.77M |
| Total Common Shares Outstanding | 535.05M | 528.18M | 396.80M | 234.27M | 191.02M | 170.27M |
| Working Capital | 483.58M | 665.14M | 526.80M | 344.97M | 469.55M | 488.06M |
| Book Value Per Share | 1.71 | 2.14 | 2.61 | 1.98 | 2.54 | 3.19 |
| Tangible Book Value | 471.76M | 658.80M | 550.05M | 374.94M | 483.70M | 540.75M |
| Tangible Book Value Per Share | 0.88 | 1.25 | 1.39 | 1.60 | 2.53 | 3.18 |
| Machinery | 121.86M | 128.29M | 82.22M | 67.69M | 53.08M | |
| Construction In Progress | 511.00K | 2.71M | 3.23M | 8.75M | 16.45M | |
| Leasehold Improvements | 70.78M | 72.73M | 45.93M | 41.87M | 13.94M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -518.88M | -644.76M | -463.66M | -328.07M | -239.48M | -186.48M |
| Depreciation & Amortization | 78.36M | 83.70M | 36.49M | 24.40M | 11.76M | 8.40M |
| Loss (Gain) From Sale of Assets | 4.50M | |||||
| Asset Writedown & Restructuring Costs | 22.08M | 28.04M | 108.00K | 1.19M | 2.81M | |
| Stock-Based Compensation | 90.72M | 111.22M | 81.69M | 53.50M | 27.91M | 14.84M |
| Other Operating Activities | 19.22M | 31.80M | 32.95M | 5.45M | 8.56M | 4.92M |
| Change in Accounts Receivable | 11.15M | 32.94M | -6.07M | -7.76M | -2.00K | -5.38M |
| Change in Accounts Payable | -7.07M | -2.62M | 6.43M | -987.00K | 1.77M | 1.75M |
| Change in Unearned Revenue | -22.94M | -36.77M | -28.04M | -41.08M | 110.32M | -10.00M |
| Change in Other Net Operating Assets | -23.11M | 20.14M | -19.08M | 5.56M | -7.16M | 13.32M |
| Operating Cash Flow | -350.48M | -371.81M | -359.17M | -287.78M | -83.52M | -158.61M |
| Capital Expenditures | -1.79M | -6.47M | -13.70M | -11.96M | -37.06M | -39.80M |
| Cash Acquisitions | 277.10M | 1.84M | ||||
| Divestitures | -4.44M | |||||
| Sale (Purchase) of Intangibles | -2.00M | -2.16M | -3.35M | -597.00K | -300.00K | |
| Investment in Securities | -2.31M | -3.81M | 480.00K | 230.61M | -231.95M | |
| Investing Cash Flow | -6.09M | -16.87M | 260.06M | -10.23M | 193.25M | -271.74M |
| Long-Term Debt Repaid | -8.43M | -4.44M | -766.00K | -90.00K | -12.80M | |
| Net Debt Issued (Repaid) | -8.75M | -8.43M | -4.44M | -766.00K | -90.00K | -12.80M |
| Issuance of Common Stock | 387.64M | 532.96M | 308.56M | 140.90M | 154.44M | 471.34M |
| Other Financing Activities | -278.00K | -3.00M | ||||
| Financing Cash Flow | 378.61M | 521.53M | 304.12M | 140.13M | 154.34M | 458.54M |
| Foreign Exchange Rate Adjustments | 937.00K | 18.04M | -3.41M | 188.00K | -307.00K | |
| Net Cash Flow | 22.98M | 150.90M | 201.60M | -157.69M | 263.76M | 28.18M |
| Free Cash Flow | -352.27M | -378.28M | -372.87M | -299.74M | -120.58M | -198.41M |
| Free Cash Flow Margin | -642.17% | -506.52% | -633.71% | -672.43% | -302.64% | -1,949.42% |
| Free Cash Flow Per Share | -0.69 | -0.84 | -1.36 | -1.44 | -0.69 | -1.58 |
| Levered Free Cash Flow | -219.49M | -208.52M | -194.33M | -187.37M | -105.41M | -121.93M |
| Unlevered Free Cash Flow | -218.57M | -207.39M | -193.35M | -187.31M | -105.37M | -120.09M |
| Cash Interest Paid | 680.00K | |||||
| Change in Working Capital | -41.98M | 13.69M | -46.76M | -44.26M | 104.92M | -306.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.30B | 2.13B | 2.67B | 2.14B | 1.46B | 2.89B |
| Enterprise Value | 1.82B | 1.55B | 2.33B | 1.80B | 1.06B | 2.32B |
| Last Close Price | 4.03 | 4.09 | 6.76 | 9.86 | 7.71 | 17.13 |
| PS Ratio | 41.90 | 28.50 | 45.31 | 47.92 | 36.68 | 284.42 |
| PB Ratio | 2.36 | 1.88 | 2.58 | 4.61 | 3.01 | 5.33 |
| P/TBV Ratio | 4.87 | 3.23 | 4.85 | 5.70 | 3.02 | 5.35 |
| EV/Sales Ratio | 33.17 | 20.77 | 39.59 | 40.38 | 26.58 | 227.62 |
| Debt / Equity Ratio | 0.07 | 0.07 | 0.10 | 0.11 | 0.10 | 0.00 |
| Net Debt / Equity Ratio | -0.52 | -0.59 | -0.47 | -0.74 | -1.03 | -0.95 |
| Net Debt / EBITDA Ratio | 1.02 | 1.18 | 1.10 | 1.05 | 2.13 | 2.96 |
| Net Debt / FCF Ratio | 1.36 | 1.76 | 1.30 | 1.14 | 4.14 | 2.60 |
| Asset Turnover | 0.04 | 0.05 | 0.06 | 0.07 | 0.06 | 0.02 |
| Quick Ratio | 4.67 | 5.20 | 3.43 | 4.24 | 5.51 | 11.27 |
| Current Ratio | 5.03 | 5.50 | 3.81 | 4.70 | 5.68 | 11.46 |
| Return on Equity (ROE) | -56.58% | -59.54% | -61.90% | -69.12% | -46.56% | -47.51% |
| Return on Assets (ROA) | -27.33% | -27.72% | -28.48% | -32.29% | -23.42% | -25.14% |
| Return on Capital Employed (ROCE) | -50.30% | -48.90% | -38.00% | -62.50% | -40.90% | -32.40% |
| Earnings Yield | -26.58% | -30.29% | -17.39% | -15.36% | -16.39% | -6.44% |
| FCF Yield | -15.33% | -17.77% | -13.98% | -14.03% | -8.25% | -6.85% |
| Buyback Yield / Dilution | -41.13% | -63.18% | -31.92% | -18.41% | -40.04% | -475.48% |